Next 10 |
home / stock / slgcw / slgcw news
2023-11-10 13:34:05 ET SomaLogic Inc. (SLGC) Q3 2023 Results Conference Call November 8, 2023 4:30 PM ET Company Participants Noah Corin - IR, Gilmartin Group Adam Taich - Interim CEO Eliot Lurier - Interim Chief Financial Officer Conference Call Participan...
2023-08-14 20:11:09 ET Somalogic, Inc. (SLGC) Q2 2023 Earnings Conference Call August 14, 2023, 16:30 ET Company Participants Marissa Bych - Group Investor Relations Adam Taich - Interim CEO Eliot Lurier - Interim CFO Conference Call Participants Kyle...
2023-06-18 04:24:59 ET Summary SomaLogic presents with a lack of fundamental, sentimental, and valuation factors to suggest a price change. I've revised my investment thesis to hold, due to the firm's Q1 results, revenue headwinds, and a market valuation of 0.8x book value. I ...
2023-05-11 21:50:30 ET SomaLogic, Inc. (SLGC) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Marissa Bych - Investor Relations, Gilmartin Group LLC Adam Taich - Chief Executive Officer Shaun Blakeman - Chief Financial Officer ...
2023-03-29 00:59:02 ET SomaLogic, Inc. (SLGC) Q4 2022 Earnings Conference Call March 27, 2023, 04:30 PM ET Company Participants Marissa Bych - Investor Relations, Gilmartin Group LLC Troy Cox - Chief Executive Officer Shaun Blakeman - Chief Financial Officer ...
Summary SomaLogic caught a strong bid in December and the rally has extended into the new year. The price change looks well supported by company-specific catalysts and market generated data. The company's niche differentiators are also attractive should they convert at the company's...
Summary We dive under the hood of one of the most controversial exchange-traded funds, analyzing their moves based on recently disclosed 13F filing data. Cathie Wood is a uniquely divisive figure in the world of finance made famous by her "disruptive innovation" investment philosophy, w...
SomaLogic, Inc. (SLGC) Q3 2022 Earnings Conference Call November 14, 2022 08:30 AM ET Company Participants Marissa Bych - Investor Relations, Gilmartin Group LLC Roy Smythe - Chief Executive Officer Shaun Blakeman - Chief Financial Officer Conference Call P...
Summary CareDx reported lackluster performance in the third quarter, with core testing revenue down by 2.5%, mirroring intensifying competitive dynamics impacting its pricing power. Competitive dynamics are exacerbated by the company's expansion in niche markets with structurally ...
Summary So far in 2022, aggressive growth names across the board have continued to be hammered into oblivion with very few pockets of strength. Since my last update, somehow, I have managed to thoroughly beat the markets in my aggressive portfolio thanks to sizable outperformances...